Search results for "AORTIC-VALVE"

showing 2 items of 2 documents

Quantitative and Qualitative Platelet Derangements in Cardiac Surgery and Extracorporeal Life Support

2021

Thrombocytopenia and impaired platelet function are known as intrinsic drawbacks of cardiac surgery and extracorporeal life supports (ECLS). A number of different factors influence platelet count and function including the inflammatory response to a cardiopulmonary bypass (CPB) or to ECLS, hemodilution, hypothermia, mechanical damage and preoperative treatment with platelet-inhibiting agents. Moreover, although underestimated, heparin-induced thrombocytopenia is still a hiccup in the perioperative management of cardiac surgical and, above all, ECLS patients. Moreover, recent investigations have highlighted how platelet disorders also affect patients undergoing biological prosthesis implanta…

medicine.medical_specialtyPlatelet disorderbiological prosthesisRESPIRATORY-FAILUREProsthesis Implantationlcsh:MedicinethrombocytopeniaReview030204 cardiovascular system & hematologyextracorporeal life supportExtracorporeallaw.invention03 medical and health sciences0302 clinical medicinelawInternal medicineCardiopulmonary bypassmedicinePlatelet030304 developmental biologyplateletUNFRACTIONATED HEPARIN0303 health sciencesCARDIOPULMONARY BYPASSbusiness.industrylcsh:RMEMBRANE-OXYGENATIONACTIVATED PLATELETSGeneral MedicineHypothermiaENDOTHELIAL-CELLSANTIBODY-FORMATIONCardiac surgeryinflammationCORONARY-ARTERY-BYPASSLife supportAORTIC-VALVE-REPLACEMENTCardiologyHEPARIN-INDUCED THROMBOCYTOPENIAmedicine.symptombusinesscardiac surgeryJournal of Clinical Medicine
researchProduct

Heart valve tissue engineering: how far is the bedside from the bench?

2015

Heart disease, including valve pathologies, is the leading cause of death worldwide. Despite the progress made thanks to improving transplantation techniques, a perfect valve substitute has not yet been developed: once a diseased valve is replaced with current technologies, the newly implanted valve still needs to be changed some time in the future. This situation is particularly dramatic in the case of children and young adults, because of the necessity of valve growth during the patient's life. Our review focuses on the current status of heart valve (HV) therapy and the challenges that must be solved in the development of new approaches based on tissue engineering. Scientists and physicia…

Aortic valveHeart diseaseSwine030204 cardiovascular system & hematology0302 clinical medicineHeart valve tissue engineeringHyaluronic AcidChildProsthetic valve0303 health sciencesMARROW-DERIVED CELLSTissue ScaffoldsFetal BloodHeart Valves3. Good healthmedicine.anatomical_structureHeart Valve ProsthesisCardiologyMolecular MedicineCollagenmedicine.medical_specialtyPULMONARY VALVEBONE-MARROWInduced Pluripotent Stem CellsVENTRICULAR OUTFLOW TRACTMESENCHYMAL STEM-CELLS03 medical and health sciencesTissue scaffoldsInternal medicineEXTRACELLULAR-MATRIXmedicineAnimalsHumansHeart valveIntensive care medicineENDOTHELIAL PROGENITOR CELLSMolecular Biology030304 developmental biologyBioprosthesisAORTIC-VALVEFibrinSheepTissue Engineeringbusiness.industryEndothelial Cellsmedicine.diseaseTransplantationPulmonary valveUMBILICAL-CORD BLOOD1182 Biochemistry cell and molecular biologybusinessHUMAN AMNIOTIC-FLUIDExpert Reviews in Molecular Medicine
researchProduct